Brief: LianBio Announces Clinical Supply Agreement With Astrazeneca In China

LianBio

12/07/2023 14:34

July 12 (Reuters) - LianBio  LIAN.O :
    * LIANBIO ANNOUNCES CLINICAL SUPPLY AGREEMENT WITH
ASTRAZENECA IN
CHINA TO EVALUATE BBP-398 IN COMBINATION WITH OSIMERTINIB IN
PATIENTS WITH NON-SMALL CELL LUNG CANCER WITH EGFR MUTATIONS
    * LIANBIO - EXPECTS TO INITIATE PHASE 1 TRIAL OF BBP-398 IN
SECOND
HALF OF 2023

Source text for Eikon:  ID:nGNX3vv18k 
Further company coverage:  LIAN.O 

 ((Reuters.Briefs@thomsonreuters.com;))